pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4457 |
Genomic Coordinates | chr5: 1309310 - 1309377 |
Description | Homo sapiens miR-4457 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4457 | |||||||||||||||||||||
Sequence | 43| UCACAAGGUAUUGACUGGCGUA |64 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | HNRNPA1 | ||||||||||||||||||||
Synonyms | ALS19, ALS20, HNRPA1, HNRPA1L3, IBMPFD3, UP 1, hnRNP A1, hnRNP-A1 | ||||||||||||||||||||
Description | heterogeneous nuclear ribonucleoprotein A1 | ||||||||||||||||||||
Transcript | NM_002136 | ||||||||||||||||||||
Other Transcripts | NM_031157 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on HNRNPA1 | |||||||||||||||||||||
3'UTR of HNRNPA1 (miRNA target sites are highlighted) |
>HNRNPA1|NM_002136|3'UTR 1 TTAGGAAACAAAGCTTAGCAGGAGAGGAGAGCCAGAGAAGTGACAGGGAAGCTACAGGTTACAACAGATTTGTGAACTCA 81 GCCAAGCACAGTGGTGGCAGGGCCTAGCTGCTACAAAGAAGACATGTTTTAGACAAATACTCATGTGTATGGGCAAAAAA 161 CTCGAGGACTGTATTTGTGACTAATTGTATAACAGGTTATTTTAGTTTCTGTTCTGTGGAAAGTGTAAAGCATTCCAACA 241 AAGGGTTTTAATGTAGATTTTTTTTTTTGCACCCCATGCTGTTGATTGCTAAATGTAACAGTCTGATCGTGACGCTGAAT 321 AAATGTCTTTTTTTTAATGTGCTGTGTAAAGTTAGTCTACTCTTAAGCCATCTTGGTAAATTTCCCCAACAGTGTGAAGT 401 TAGAATTCCTTCAGGGTGATGCCAGGTTCTATTTGGAATTTATATACAACCTGCTTGGGTGGAGAAGCCATTGTCTTCGG 481 AAACCTTGGTGTAGTTGAACTGATAGTTACTGTTGTGACCTGAAGTTCACCATTAAAAGGGATTACCCAAGCAAAATCAT 561 GGAATGGTTATAAAAGTGATTGTTGGCACATCCTATGCAATATATCTAAATTGAATAATGGTACCAGATAAAATTATAGA 641 TGGGAATGAAGCTTGTGTATCCATTATCATGTGTAATCAATAAACGATTTAATTCTCTTGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177608. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_10
PAR-CLIP data was present in ERX177616. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_6
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177631. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_9
PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
PAR-CLIP data was present in ERX177607. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_9
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000546500.1 | 3UTR | UCCUUGUGAAGACCUUUAUCUGAGCCACUGUACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000546500.1 | 3UTR | UCCUUGUGAAGACCUUUAUCUGAGCCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
83 hsa-miR-4457 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT098032 | SOBP | sine oculis binding protein homolog | 2 | 2 | ||||||||
MIRT202580 | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 | 2 | 6 | ||||||||
MIRT247137 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT349266 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT363756 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT443586 | FAM84B | family with sequence similarity 84 member B | 2 | 2 | ||||||||
MIRT452333 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT453864 | ZBTB40 | zinc finger and BTB domain containing 40 | 2 | 4 | ||||||||
MIRT471486 | PDE4D | phosphodiesterase 4D | 2 | 4 | ||||||||
MIRT476290 | GMFB | glia maturation factor beta | 2 | 8 | ||||||||
MIRT479897 | CCDC117 | coiled-coil domain containing 117 | 2 | 4 | ||||||||
MIRT484251 | ANK1 | ankyrin 1 | 2 | 2 | ||||||||
MIRT491473 | TMEM214 | transmembrane protein 214 | 2 | 2 | ||||||||
MIRT493804 | GAN | gigaxonin | 2 | 6 | ||||||||
MIRT499252 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT502271 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 4 | ||||||||
MIRT504651 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT505211 | UBN2 | ubinuclein 2 | 2 | 8 | ||||||||
MIRT508952 | SNRPB | small nuclear ribonucleoprotein polypeptides B and B1 | 2 | 4 | ||||||||
MIRT512691 | POP1 | POP1 homolog, ribonuclease P/MRP subunit | 2 | 2 | ||||||||
MIRT513320 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT513870 | HOXA5 | homeobox A5 | 2 | 2 | ||||||||
MIRT517342 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT518947 | LSG1 | large 60S subunit nuclear export GTPase 1 | 2 | 2 | ||||||||
MIRT520867 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 2 | ||||||||
MIRT528325 | GIGYF2 | GRB10 interacting GYF protein 2 | 2 | 2 | ||||||||
MIRT531990 | SLCO1B3 | solute carrier organic anion transporter family member 1B3 | 2 | 2 | ||||||||
MIRT533298 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT545257 | TRIM36 | tripartite motif containing 36 | 2 | 4 | ||||||||
MIRT547038 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT556103 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT558321 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT558521 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT560906 | TMED10 | transmembrane p24 trafficking protein 10 | 2 | 2 | ||||||||
MIRT568448 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT570586 | OTUD7B | OTU deubiquitinase 7B | 2 | 2 | ||||||||
MIRT572799 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT573863 | C9orf78 | chromosome 9 open reading frame 78 | 2 | 2 | ||||||||
MIRT575058 | P2ry1 | purinergic receptor P2Y, G-protein coupled 1 | 2 | 5 | ||||||||
MIRT609931 | SLC38A1 | solute carrier family 38 member 1 | 2 | 4 | ||||||||
MIRT610836 | ZNF585A | zinc finger protein 585A | 2 | 4 | ||||||||
MIRT611474 | P2RY1 | purinergic receptor P2Y1 | 2 | 7 | ||||||||
MIRT613569 | YY2 | YY2 transcription factor | 2 | 2 | ||||||||
MIRT618626 | GREB1 | growth regulation by estrogen in breast cancer 1 | 2 | 2 | ||||||||
MIRT620606 | SAP30 | Sin3A associated protein 30 | 2 | 2 | ||||||||
MIRT621017 | CLSTN3 | calsyntenin 3 | 2 | 4 | ||||||||
MIRT635314 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT635919 | GLTSCR2 | NOP53 ribosome biogenesis factor | 2 | 2 | ||||||||
MIRT640598 | TM9SF4 | transmembrane 9 superfamily member 4 | 2 | 2 | ||||||||
MIRT641784 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | 2 | 4 | ||||||||
MIRT644067 | IQCE | IQ motif containing E | 2 | 2 | ||||||||
MIRT648288 | TRAPPC2L | trafficking protein particle complex 2 like | 2 | 2 | ||||||||
MIRT658085 | FOXR2 | forkhead box R2 | 2 | 2 | ||||||||
MIRT659077 | DEPTOR | DEP domain containing MTOR interacting protein | 2 | 2 | ||||||||
MIRT665307 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT665975 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT666302 | SLC25A25 | solute carrier family 25 member 25 | 2 | 2 | ||||||||
MIRT674906 | RASSF9 | Ras association domain family member 9 | 2 | 2 | ||||||||
MIRT680086 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT681488 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT691244 | DFNB59 | pejvakin | 2 | 2 | ||||||||
MIRT692362 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT693035 | MB21D1 | Mab-21 domain containing 1 | 2 | 2 | ||||||||
MIRT693837 | STAT5A | signal transducer and activator of transcription 5A | 2 | 2 | ||||||||
MIRT694479 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT696070 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT696578 | TTC21B | tetratricopeptide repeat domain 21B | 2 | 2 | ||||||||
MIRT696760 | MTFMT | mitochondrial methionyl-tRNA formyltransferase | 2 | 2 | ||||||||
MIRT697307 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT700152 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT701056 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT701198 | OTUD3 | OTU deubiquitinase 3 | 2 | 2 | ||||||||
MIRT701335 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT702656 | ITGA3 | integrin subunit alpha 3 | 2 | 2 | ||||||||
MIRT703618 | FBXO45 | F-box protein 45 | 2 | 2 | ||||||||
MIRT704673 | CHTOP | chromatin target of PRMT1 | 2 | 2 | ||||||||
MIRT708894 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT711620 | DGKH | diacylglycerol kinase eta | 2 | 2 | ||||||||
MIRT713745 | TMEM81 | transmembrane protein 81 | 2 | 2 | ||||||||
MIRT719712 | CD101 | CD101 molecule | 2 | 2 | ||||||||
MIRT720294 | DLGAP3 | DLG associated protein 3 | 2 | 2 | ||||||||
MIRT722606 | CCDC152 | coiled-coil domain containing 152 | 2 | 2 | ||||||||
MIRT724566 | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|